Elvina Almuradova: From Dose-Finding to Dose-Optimization in Early-Phase Oncology Clinical Trials
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an article on LinkedIn:
“Excited to share our latest publication in Cancer Treatment Reviews: “From Dose-Finding to Dose-Optimization in Early-Phase Oncology Clinical Trials”.
We discuss the evolution from traditional dose-escalation (like 3+3) toward modern, model-based strategies that prioritize patient safety, biomarkers, and precision.
Grateful to my co-authors—and especially to Dr Dario Trapani and mentor Prof. Giuseppe Curigliano —for their invaluable support.”
From Dose-Finding to Dose-Optimization in Early-Phase oncology clinical trials.
Authors: Elvina Almuradova, Davide Izzo, Sara Gandini, Aurora Gaeta, Edoardo Giordano, Carmine Valenza, Gabriele Antonarelli, Dario Trapani, Giuseppe Curigliano.
You can Read the Full Article on Journal of Cancer Treatment Reviews.
More posts featuring Elvina Almuradova.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023